MedPath

Fat Quality and Postprandial Inflammation

Not Applicable
Completed
Conditions
Inflammation
Inflammatory Response
Interventions
Other: Fat intake
Registration Number
NCT05674708
Lead Sponsor
Göteborg University
Brief Summary

This aim of this randomized controlled postprandial study is to compare the effects of four different far sources (butter, coconut, corn oil and flax seed oil) on postprandial inflammation and metabolic response.

The main questions it aims to answer are:

1. What is the impact of different dietary sources of saturated and polyunsaturated fatty acids on postprandial inflammation?

2. Is the impact of different dietary sources of saturated and polyunsaturated fatty acids on postprandial inflammation mediated by glucose or blood lipids?

3. Can postprandial inflammatory or metabolic response be predicted by individual factors at baseline?

Participants will consume four meals, identical except for the fat source, in random order and sampled for blood and urine for up to 6 hours.

Detailed Description

A randomized crossover single meal study will be conducted, comparing four isocaloric meals. The study will be carried out at two sites; one study center is located in Gothenburg, Sweden (Department of Internal Medicine and Clinical Nutrition at the University of Gothenburg) and one study center in Oslo, Norway (Department of Nutrition, University of Oslo).

A total of 20 healthy adults will be recruited and consume four meals, identical except for the fat source, in random order and sampled for blood and urine for up to 6 hours after. Each of the four meals will be separated by a 1 month washout. Subjects will be asked to abstain from rigorous physical activity, alcohol and high-fat foods the day prior to their test meal days.

Four isocaloric high-fat meals with different fatty acid profiles will be compared:

1. butter

2. coconut oil

3. corn oil

4. flax seed oil

At test meal days, study outcomes will be assessed at baseline (0h, fasting, pre meal), 30 min, 1h, 2h, 4h and at 6h (endpoint). At these timepoints, blood pressure will be measured and blood glucose sampled through capillary blood. At baseline, 2h, 4h and 6h, blood will be drawn by venipuncture. Urine will be collected when the participants need to void.

Blood will be collected and handled according to a standardized protocol to prevent any degradation, before stored in -80°C until analysis. At baseline and endpoint, peripheral blood mononuclear cells from blood samples will be isolated using cell preparation tubes and stored at -80 °C until RNA isolation. Lipids, lipoprotein profile and inflammation markers (e.g. cytokines, chemokines, endothelial factors) will be analyzed in samples from 0, 2, 4 and 6 hours.

Differences between meals in the outcomes will be compared using area under the curve and mixed models effect.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
18
Inclusion Criteria
  • BMI >18.5
  • Willingness to eat study meals
Exclusion Criteria
  • Diabetes
  • Cardiovascular disease
  • Cancer
  • Dyslipidemia
  • Anemia (Hb <100)
  • Habitual intake of anti-inflammatory drugs
  • Recent weight change (>±5%)
  • Pregnancy, lactation
  • Current smoking

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Corn oilFat intakeCorn oil based meal
ButterFat intakeButter based meal
Flax seed oilFat intakeFlax seed oil based meal
CoconutFat intakeCoconut based meal
Primary Outcome Measures
NameTimeMethod
Inflammation markers0, 2, 4 and 6 hours

Cytokines, chemokines, endothelial factors

Secondary Outcome Measures
NameTimeMethod
Blood pressure0, 0.5, 1, 2, 4, 6 hours

Systolic and diastolic

Gene expression0 and 4 hours

Gene expression in peripheral blood mononuclear cells in a subset (N=10) participants

Lipidomics0, 2, 4 and 6 hours

Lipidomics characterization of lipid classes

Lipoproteins0, 2, 4 and 6 hours

Triglycerides, VLDL

Blood glucose0, 0.5, 1, 2, 4, 6 hours

Capillary glucose sampling

Trial Locations

Locations (1)

University of Gothenburg

🇸🇪

Göteborg, Sweden

© Copyright 2025. All Rights Reserved by MedPath